[HTML][HTML] Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly …
The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline
for Diabetes Management in Chronic Kidney Disease (CKD) represents a focused update of …
for Diabetes Management in Chronic Kidney Disease (CKD) represents a focused update of …
Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice
Patients with type 2 diabetes mellitus (T2DM) can have multiple comorbidities and
premature mortality due to atherosclerotic cardiovascular disease, hospitalization with heart …
premature mortality due to atherosclerotic cardiovascular disease, hospitalization with heart …
Diabetes management in chronic kidney disease: synopsis of the KDIGO 2022 clinical practice guideline update
SD Navaneethan, S Zoungas, ML Caramori… - Annals of internal …, 2023 - acpjournals.org
Description: The KDIGO 2022 Clinical Practice Guideline for Diabetes Management in
Chronic Kidney Disease is an update of the 2020 guideline from Kidney Disease: Improving …
Chronic Kidney Disease is an update of the 2020 guideline from Kidney Disease: Improving …
Age-specific population attributable risk factors for all-cause and cause-specific mortality in type 2 diabetes: An analysis of a 6-year prospective cohort study of over …
Background The prevalence of type 2 diabetes has increased in both young and old people.
We examined age-specific associations and population attributable fractions (PAFs) of risk …
We examined age-specific associations and population attributable fractions (PAFs) of risk …
The case for precision medicine in the prevention, diagnosis, and treatment of cardiometabolic diseases in low-income and middle-income countries
Cardiometabolic diseases are the leading preventable causes of death in most
geographies. The causes, clinical presentations, and pathogenesis of cardiometabolic …
geographies. The causes, clinical presentations, and pathogenesis of cardiometabolic …
Precision prognostics for cardiovascular disease in type 2 diabetes: a systematic review and meta-analysis
Background Precision medicine has the potential to improve cardiovascular disease (CVD)
risk prediction in individuals with Type 2 diabetes (T2D). Methods We conducted a …
risk prediction in individuals with Type 2 diabetes (T2D). Methods We conducted a …
Global trends in the burden of chronic kidney disease attributable to type 2 diabetes: An age‐period‐cohort analysis
W Liu, D Zhang, R Wang, J Chen… - Diabetes, Obesity …, 2024 - Wiley Online Library
Aim To assess temporal trends of chronic kidney disease (CKD) attributable to type 2
diabetes (T2D) globally and in five sociodemographic index (SDI) regions. Materials and …
diabetes (T2D) globally and in five sociodemographic index (SDI) regions. Materials and …
Real‐world usage of sulphonylureas in Asian patients with type 2 diabetes using the Joint Asia Diabetes Evaluation (JADE) register
Aims To explore the patterns of use of oral glucose‐lowering drugs (OGLDs) in Asian
patients with type 2 diabetes (T2D), focusing on sulphonylureas (SUs), and to describe …
patients with type 2 diabetes (T2D), focusing on sulphonylureas (SUs), and to describe …
Current type 2 diabetes guidelines: Individualized treatment and how to make the most of metformin
Evidence‐based guidelines provide the premise for the delivery of quality care to preserve
health and prevent disabilities and premature death. The systematic gathering of …
health and prevent disabilities and premature death. The systematic gathering of …
Combined associations of family history and self-management with age at diagnosis and cardiometabolic risk in 86,931 patients with type 2 diabetes: Joint Asia …
JTK Cheung, E Lau, CCT Tsui, ELN Siu, NKW Tse… - BMC medicine, 2022 - Springer
Abstract Background Family history (FamH) of type 2 diabetes might indicate shared
genotypes, environments, and/or behaviors. We hypothesize that FamH interacts with …
genotypes, environments, and/or behaviors. We hypothesize that FamH interacts with …